Matthew co-leads Deloitte’s Artificial Intelligence ‘Disruptor’ - focused on client services and internal transformation. His background includes academic research, start-up biotech, Big Pharma, IBM Watson, and Deloitte Innovation. Prior to Deloitte, Matthew was the European Head of IBM Watson Health, focused on taking platforms such as Watson Oncology and Watson Genomics to market. Matthew now works cross industry to help clients understand the opportunities of rapidly evolving Artificial Intelligence and Cognitive technologies, how to innovate using them and how to move from the hype to real use cases and implementation. The objective of Deloitte’s AI team is to help our clients not only build cognitive strategies but also get their hands on real technology. We form joint client-Deloitte innovation teams to rapidly build prototypes and flesh out use cases, using a range of vendors including IBM Watson, Google, and Microsoft. Recent projects include using machine learning to predict financial services complaint outcomes and speed up processing time, and the use of AI to provide customer services. We help our clients take a proportionate approach to investment to support business led decision making, all based on a robust understanding – and experience of – these exciting new technologies.